A peer-reviewed, evidence-based journal that promotes clinical development and metabolic insights in total bariatric patient care for the healthcare professional
Issue link: https://bariatrictimes.epubxp.com/i/295392
A2 Bariatric Times [MAY 2014, SUPPLEMENT A] Funded by Cadence Pharmaceuticals, Inc. © 2014 Matrix Medical Communications. All rights reserved. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Matrix Medical Communications, the editorial staff, or any member of the editorial advisory board. Matrix Medical Communications is not responsible for accuracy of dosages given in the articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Matrix Medical Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements. Reprints are available. Contact Matrix Medical Communications for information. Bariatric Times (ISSN 1551-3572) is published by Matrix Medical Communications, 1595 Paoli Pike, Ste. 201, West Chester, PA 19380. Telephone: (866) 325-9907 or (484) 266-0702, Fax: (484) 266- 0726. Printed in USA. Matrix Medical Communications 1595 Paoli Pike, Suite 201 West Chester, PA 19380 THE ROLE OF MULTIMODAL ANALGESIA IN BARIATRIC SURGERY TABLE OF CONTENTS Authors A Review of Clinical Data and Case-Based Presentations Featuring OFIRMEV ® (acetaminophen) Injection • Introduction .....................................................................A3 • Unmet Need in Pain Management..................................A3 • Multimodal Approach to Pain Management ................A3 • OFIRMEV ® (acetaminophen) Injection ..........................A3 • Clinical Pharmacology of OFIRMEV ............................A4 • Clinical Considerations Regarding Route of Administration ............................................................A4 • Analgesic Efficacy of OFIRMEV ....................................A5 • Preemptive Analgesic Efficacy of OFIRMEV ................A6 • Reduced Opioid Consumption with OFIRMEV ...........A6 • Improved Patient Satisfaction with OFIRMEV ...........A7 • Clinical Safety of OFIRMEV ..........................................A7 • Recommended Dosing of OFIRMEV ..............................A8 • Conclusion ........................................................................A8 • Case Study 1: Sleeve Gastrectomy .................................A9 by Anthony Gonzalez, MD • Case Study 2: Roux-en-Y Gastric Bypass ......................A9 by Patrick Ziemann-Gimmel, MD • Important Safety Information........................................A10 Chief of Surgery, Baptist Hospital of Miami; Medical Director, Bariatric Surgery, South Miami Hospital; Assistant Professor of Surgery, Florida International University College of Medicine, Miami, Florida Anthony Gonzalez, MD Anesthesiologist, Flagler Hospital, St. Augustine, Florida Patrick Ziemann-Gimmel, MD C L I N I C A L , E V I D E N C E - B A S E D I N F O R M A T I O N V O L U M E 1 1 , N U M B E R 5 • M A Y 2 0 1 4 • S U P P L E M E N T A EDITED-Cadence Ofirmez Suppl copy 2_Layout 1 4/14/14 10:13 AM Page A2